Abstract
Antibodies directed against membrane antigens of neuronal axonal processes (neuropil) have been recently identified in neuro-Behcet’s disease (NBD) patients. To delineate the potential pathogenic action of these antibodies, pooled sera from seven NBD patients with neuropil antibodies and seven healthy controls were divided into purified IgG and IgG-depleted serum (IgG-DS) fractions and each fraction was administered into lateral ventricles of rats. NBD IgG-injected rats showed reduced locomotor activity in the open field test as compared to NBD IgG-DS, healthy control IgG, healthy control IgG-DS and PBS injected rats (n = 10 for each group). There were no significant differences among treatment groups by means of anxiety-like behaviors (assessed by elevated plus maze test) and learning/memory functions (assessed by passive avoidance test). Administration of NBD IgG on cultured SH-SY5Y neuroblastoma cells induced significantly increased cell death and apoptosis (as measured by nucleosome levels in the supernatants) as compared to other treatment groups. Our results suggest that IgGs isolated from sera of neuropil antibody-positive NBD patients have a neurotoxic action, which is presumably mediated by apoptotic mechanisms. Motor deficits frequently observed in NBD patients might at least partially be caused by the pathogenic action of anti-neuronal IgG.
Similar content being viewed by others
References
Gül A (2015) Pathogenesis of Behçet’s disease: autoinflammatory features and beyond. Semin Immunopathol 37:413–418
Saip S, Akman-Demir G, Siva A (2014) Neuro-Behçet syndrome. Handb Clin Neurol 121:1703–1723
Akman-Demir G, Serdaroglu P, Tasçi B (1999) Clinical patterns of neurological involvement in Behçet’s disease: evaluation of 200 patients. The Neuro-Behçet Study Group. Brain 122:2171–2182
Yesilot N, Shehu M, Oktem-Tanor O, Serdaroglu P, Akman-Demir G (2006) Silent neurological involvement in Behçet’s disease. Clin Exp Rheumatol 24:S65–S70
Akman-Demir G, Mutlu M, Kiyat-Atamer A et al (2015) Behçet’s disease patients with multiple sclerosis-like features: discriminative value of Barkhof criteria. Clin Exp Rheumatol 33:S80–S84
Vural B, Uğurel E, Tüzün E et al (2011) Anti-neuronal and stress-induced-phosphoprotein 1 antibodies in neuro-Behçet’s disease. J Neuroimmunol 239:91–97
Vural B, Sehitoğlu E, Cavuş F et al (2013) Mitochondrial carrier homolog 1 (Mtch1) antibodies in neuro-Behçet’s disease. J Neuroimmunol 263:139–144
Taşçi B, Direskeneli H, Serdaroglu P, Akman-Demir G, Eraksoy M, Saruhan-Direskeneli G (1998) Humoral immune response to mycobacterial heat shock protein (hsp)65 in the cerebrospinal fluid of neuro-Behçet patients. Clin Exp Immunol 113:100–104
Gheita TA, Samir H, Hussein H (2012) Anti-annexin V antibodies in neuro-Behçet patients: clinical significance and relation to disease activity. Int J Rheum Dis 15:e124–e126
Planagumà J, Leypoldt F, Mannara F et al (2015) Human N-methyl d-aspartate receptor antibodies alter memory and behaviour in mice. Brain 138:94–109
Ohkawa T, Fukata Y, Yamasaki M et al (2013) Autoantibodies to epilepsy-related LGI1 in limbic encephalitis neutralize LGI1-ADAM22 interaction and reduce synaptic AMPA receptors. J Neurosci 33:18161–18174
International Study Group for Behcet’s Disease (1990) Criteria for diagnosis of Behcet’s disease. Lancet 335:1078–1080
Irani SR, Alexander S, Waters P et al (2010) Antibodies to Kv1 potassium channel-complex proteins leucine-rich, glioma inactivated 1 protein and contactin-associated protein-2 in limbic encephalitis, Morvan’s syndrome and acquired neuromyotonia. Brain 133:2734–2748
Furneaux HM, Rosenblum MK, Dalmau J, Wong E, Woodruff P, Graus F, Posner JB (1990) Selective expression of Purkinje-cell antigens in tumor tissue from patients with paraneoplastic cerebellar degeneration. N Engl J Med 322:1844–1851
Cattoretti G, Pileri S, Parravicini C et al (1993) Antigen unmasking on formalin-fixed, paraffin-embedded tissue sections. J Pathol 171:83–98
Tüzün E, Zhou L, Baehring JM, Bannykh S, Rosenfeld MR, Dalmau J (2009) Evidence for antibody-mediated pathogenesis in anti-NMDAR encephalitis associated with ovarian teratoma. Acta Neuropathol 118:737–743
Dalmau J, Gultekin SH, Voltz R et al (1999) Ma1, a novel neuron- and testis-specific protein, is recognized by the serum of patients with paraneoplastic neurological disorders. Brain 122:27–39
Verschuuren JJ, Dalmau J, Hoard R, Posner JB (1997) Paraneoplastic anti-Hu serum: studies on human tumor cell lines. J Neuroimmunol 79:202–210
Colpak AI, Gursoy-Ozdemir Y, Kalyoncu U (2014) Sera from patients with neuro-Behcet’s disease contain autoantibodies against vascular and nervous tissue. Arch Neuropsychiatr 51:141–147
Gasperi C, Stüve O, Hemmer B (2016) B cell-directed therapies in multiple sclerosis. Neurodegener Dis Manag 6:37–47
Hohlfeld R, Dornmair K, Meinl E, Wekerle H (2016) The search for the target antigens of multiple sclerosis, part 2: CD8+ T cells, B cells, and antibodies in the focus of reverse-translational research. Lancet Neurol 15:317–331
Krumbholz M, Derfuss T, Hohlfeld R, Meinl E (2012) B cells and antibodies in multiple sclerosis pathogenesis and therapy. Nat Rev Neurol 8:613–623
Meinl E, Derfuss T, Krumbholz M, Pröbstel AK, Hohlfeld R (2011) Humoral autoimmunity in multiple sclerosis. J Neurol Sci 306:180–182
Seider N, Beiran I, Scharf J, Miller B (2001) Intravenous immunoglobulin therapy for resistant ocular Behçet’s disease. Br J Ophthalmol 85:1287–1288
Erdoğan S, Sorgun MH, Yalçındağ N, Atilla H, Yücesan C (2015) Bilateral optic neuritis in a patient with Behçet’s disease who respond to therapeutic plasma exchange. Saudi J Ophthalmol 29:298–300
Kidd DP (2015) Rituximab is effective in severe treatment-resistant neurological Behçet’s syndrome. J Neurol 262:2676–2677
Kowal C, Degiorgio LA, Lee JY, Edgar MA, Huerta PT, Volpe BT, Diamond B (2006) Human lupus autoantibodies against NMDA receptors mediate cognitive impairment. Proc Natl Acad Sci USA 103:19854–19859
Acknowledgements
This study was supported by The Istanbul University Department of Scientific Research Projects (Project Nos: 31478 and 46421) and The Scientific and Technological Research Council of Turkey (TÜBİTAK) (Project No: 113S570).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
Authors declare no conflict of interest.
Rights and permissions
About this article
Cite this article
Erdağ, E., Şahin, C., Küçükali, C.İ. et al. Effects of in vivo and in vitro administration of neuro-Behcet’s disease IgG. Neurol Sci 38, 833–843 (2017). https://doi.org/10.1007/s10072-017-2856-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10072-017-2856-2